UBS raised the firm’s price target on Nutanix (NTNX) to $91 from $81 and keeps a Buy rating on the shares. Nutanix delivered clean beats and raises across the board, with business activity aligning to the firm’s recent positive partner checks, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTNX:
- Nutanix upgraded to Outperform from Market Perform at Northland
- Nutanix upgraded to Outperform at Northland with ARR growth inflecting
- Nutanix: Strong Performance and Promising Prospects Justify Buy Rating
- Nutanix price target raised to $88 from $83 at Piper Sandler
- Nutanix: Strong Market Position and Growth Prospects Justify Buy Rating